Is systemic mastocytosis in the bone marrow concerning when you have CMML-1, and can it be treated?
Having systemic mastocytosis alongside CMML-1 does add complexity to your condition. Systemic mastocytosis involves a buildup of mast cells in organs including the bone marrow, which can cause inflammation and allergic Show Full Answer
Is systemic mastocytosis in the bone marrow concerning when you have CMML-1, and can it be treated?
Having systemic mastocytosis alongside CMML-1 does add complexity to your condition. Systemic mastocytosis involves a buildup of mast cells in organs including the bone marrow, which can cause inflammation and allergic reactions. When mast cells accumulate in the bone marrow, they can interfere with normal blood cell production, similar to how CMML affects your blood counts.
The severity depends on the type of systemic mastocytosis you have. Some forms are milder and more manageable, while aggressive forms can progress and cause organ damage.
Both conditions are treatable, though the approach depends on your specific situation:
For CMML-1:
- Chemotherapy to lower white blood cell counts
- Bone marrow transplant (potentially curative if you're a candidate)
- Supportive care to manage symptoms
For systemic mastocytosis:
- Targeted therapy like Rydapt (midostaurin), which blocks proteins that help abnormal mast cells grow
- Treatments to reduce mast cell levels
- Symptom management
Because both conditions affect your bone marrow, your treatment plan will need to address both issues. Your doctor can help determine the best approach based on your blast cell counts, mast cell levels, and overall health.
It's important to work closely with your healthcare team to monitor both conditions and adjust treatment as needed.
March 22
Join
Your Privacy Choices
